These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32872068)

  • 21. Dopa-responsive dystonia simulating spastic paraplegia due to tyrosine hydroxylase (TH) gene mutations.
    Furukawa Y; Graf WD; Wong H; Shimadzu M; Kish SJ
    Neurology; 2001 Jan; 56(2):260-3. PubMed ID: 11160968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parkinsonism without dopamine neuron degeneration in aged l-dopa-responsive dystonia knockin mice.
    Rose SJ; Harrast P; Donsante C; Fan X; Joers V; Tansey MG; Jinnah HA; Hess EJ
    Mov Disord; 2017 Dec; 32(12):1694-1700. PubMed ID: 28949038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study of a fetal brain affected by a severe form of tyrosine hydroxylase deficiency, a rare cause of early parkinsonism.
    Tristán-Noguero A; Díez H; Jou C; Pineda M; Ormazábal A; Sánchez A; Artuch R; Garcia-Cazorla À
    Metab Brain Dis; 2016 Jun; 31(3):705-9. PubMed ID: 26686676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetics and biochemistry of dopa-responsive dystonia: significance of striatal tyrosine hydroxylase protein loss.
    Furukawa Y
    Adv Neurol; 2003; 91():401-10. PubMed ID: 12442699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An unusual presentation of tyrosine hydroxylase deficiency.
    Katus LE; Frucht SJ
    J Clin Mov Disord; 2017; 4():18. PubMed ID: 29225908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Levalbuterol lowers the feedback inhibition by dopamine and delays misfolding and aggregation in tyrosine hydroxylase.
    Flydal MI; Kråkenes TA; Tai MDS; Tran MPA; Teigen K; Martinez A
    Biochimie; 2021 Apr; 183():126-132. PubMed ID: 33309753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebrospinal fluid synaptic proteins as useful biomarkers in tyrosine hydroxylase deficiency.
    Ortez C; Duarte ST; Ormazábal A; Serrano M; Pérez A; Pons R; Pineda M; Yapici Z; Fernández-Álvarez E; Domingo-Jiménez R; De Castro P; Artuch R; García-Cazorla A
    Mol Genet Metab; 2015 Jan; 114(1):34-40. PubMed ID: 25468651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopa-responsive dystonia--clinical and genetic heterogeneity.
    Wijemanne S; Jankovic J
    Nat Rev Neurol; 2015 Jul; 11(7):414-24. PubMed ID: 26100751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular analyses of GCH-1, TH and parkin genes in Chinese dopa-responsive dystonia families.
    Wu ZY; Lin Y; Chen WJ; Zhao GX; Xie H; Murong SX; Wang N
    Clin Genet; 2008 Dec; 74(6):513-21. PubMed ID: 18554280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopa-Responsive Dystonia in Han Chinese Patients: One Novel Heterozygous Mutation in GTP Cyclohydrolase 1 (GCH1) and Three Known Mutations in TH.
    Yang K; Yin R; Lan X; Zhang Y; Cheng H; Wang S; Wang C; Lu Y; Xi J; Lu Q; Huang J; Chen Y
    Med Sci Monit; 2018 Feb; 24():751-757. PubMed ID: 29405179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopa-responsive dystonia with a novel initiation codon mutation in the GCH1 gene misdiagnosed as cerebral palsy.
    Lee JH; Ki CS; Kim DS; Cho JW; Park KP; Kim S
    J Korean Med Sci; 2011 Sep; 26(9):1244-6. PubMed ID: 21935284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Compound Heterozygote for GCH1 Mutation Represents a Case of Atypical Dopa-Responsive Dystonia.
    Giri S; Naiya T; Roy S; Das G; Wali GM; Das SK; Ray K; Ray J
    J Mol Neurosci; 2019 Jun; 68(2):214-220. PubMed ID: 30911941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopamine transporter density measured by [123I]beta-CIT single-photon emission computed tomography is normal in dopa-responsive dystonia.
    Jeon BS; Jeong JM; Park SS; Kim JM; Chang YS; Song HC; Kim KM; Yoon KY; Lee MC; Lee SB
    Ann Neurol; 1998 Jun; 43(6):792-800. PubMed ID: 9629849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tyrosine hydroxylase deficiency causes progressive encephalopathy and dopa-nonresponsive dystonia.
    Hoffmann GF; Assmann B; Bräutigam C; Dionisi-Vici C; Häussler M; de Klerk JB; Naumann M; Steenbergen-Spanjers GC; Strassburg HM; Wevers RA
    Ann Neurol; 2003; 54 Suppl 6():S56-65. PubMed ID: 12891655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential involvement of striosome and matrix dopamine systems in a transgenic model of dopa-responsive dystonia.
    Sato K; Sumi-Ichinose C; Kaji R; Ikemoto K; Nomura T; Nagatsu I; Ichinose H; Ito M; Sako W; Nagahiro S; Graybiel AM; Goto S
    Proc Natl Acad Sci U S A; 2008 Aug; 105(34):12551-6. PubMed ID: 18713855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Striatal biopterin and tyrosine hydroxylase protein reduction in dopa-responsive dystonia.
    Furukawa Y; Nygaard TG; Gütlich M; Rajput AH; Pifl C; DiStefano L; Chang LJ; Price K; Shimadzu M; Hornykiewicz O; Haycock JW; Kish SJ
    Neurology; 1999 Sep; 53(5):1032-41. PubMed ID: 10496263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variability of clinical expression and evolution of spinal deformity in a family with late detection of dopa-responsive dystonia.
    Tsirikos AI; Carr LJ; Noordeen HH
    Dev Med Child Neurol; 2004 Feb; 46(2):128-37. PubMed ID: 14974638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Levodopa-induced dyskinesias in tyrosine hydroxylase deficiency.
    Pons R; Syrengelas D; Youroukos S; Orfanou I; Dinopoulos A; Cormand B; Ormazabal A; Garzía-Cazorla A; Serrano M; Artuch R
    Mov Disord; 2013 Jul; 28(8):1058-63. PubMed ID: 23389938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of
    Li XY; Yang YM; Li LB; Zhang MY; Huang YY; Wang J; Wang L; Wan XH
    Front Neurol; 2021; 12():644910. PubMed ID: 34054692
    [No Abstract]   [Full Text] [Related]  

  • 40. The quaternary structure of human tyrosine hydroxylase: effects of dystonia-associated missense variants on oligomeric state and enzyme activity.
    Szigetvari PD; Muruganandam G; Kallio JP; Hallin EI; Fossbakk A; Loris R; Kursula I; Møller LB; Knappskog PM; Kursula P; Haavik J
    J Neurochem; 2019 Jan; 148(2):291-306. PubMed ID: 30411798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.